Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation

BACKGROUND: Cancer immunotherapeutic strategies showed unprecedented results in the clinic. However, many patients do not respond to immuno-oncological treatments due to the occurrence of a plethora of immunological obstacles, including tumor intrinsic mechanisms of resistance to cytotoxic T-cell (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrentino, Antonio, Menevse, Ayse Nur, Michels, Tillmann, Volpin, Valentina, Durst, Franziska Christine, Sax, Julian, Xydia, Maria, Hussein, Abir, Stamova, Slava, Spoerl, Steffen, Heuschneider, Nicole, Muehlbauer, Jasmin, Jeltsch, Katharina Marlene, Rathinasamy, Anchana, Werner-Klein, Melanie, Breinig, Marco, Mikietyn, Damian, Kohler, Christian, Poschke, Isabel, Purr, Sabrina, Reidell, Olivia, Martins Freire, Catarina, Offringa, Rienk, Gebhard, Claudia, Spang, Rainer, Rehli, Michael, Boutros, Michael, Schmidl, Christian, Khandelwal, Nisit, Beckhove, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174898/
https://www.ncbi.nlm.nih.gov/pubmed/35606086
http://dx.doi.org/10.1136/jitc-2021-004258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174898/
https://www.ncbi.nlm.nih.gov/pubmed/35606086
http://dx.doi.org/10.1136/jitc-2021-004258

Ejemplares similares